SPRING PHARMACEUTICAL GROUP, INC.: 10-Q filed 2019-02-14
What SPRING PHARMACEUTICAL GROUP, INC. reported in its quarterly report filed 2019-02-14 (fiscal Q3 2019): 36 published measures, 96 facts as tagged in accession 0001096906-19-000070.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-02-14
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001096906-19-000070 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All SPRING PHARMACEUTICAL GROUP, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 114,301,309 | USD | |
| At 2018-03-31 | 110,138,099 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 108,953,612 | USD | |
| At 2018-03-31 | 105,106,585 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 35,962,549 | USD | |
| At 2018-03-31 | 25,353,360 | USD | |
| At 2017-12-31 | 18,768,536 | USD | |
| At 2017-03-31 | 10,308,622 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 4,475,609 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 13,308,062 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 2,862,281 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 9,095,525 | USD | 275 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-12-31 | 91,582 | USD | 275 |
| 2017-04-01 to 2017-12-31 | 2,125,638 | USD | 275 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 19,494,574 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 59,068,360 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 17,211,156 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 48,212,805 | USD | 275 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-12-31 | -742,674 | USD | 275 |
| 2017-04-01 to 2017-12-31 | -4,453,916 | USD | 275 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 107,356,757 | USD | |
| At 2018-03-31 | 94,447,937 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 1,491,869 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 4,436,020 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 954,093 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 3,031,841 | USD | 275 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 14,492,277 | USD | |
| At 2018-03-31 | 16,793,413 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 5,932,337 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 17,633,896 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 3,783,998 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 11,465,596 | USD | 275 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 41,776,992 | USD | |
| At 2018-03-31 | 30,065,747 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 2,181,279 | USD | |
| At 2018-03-31 | 1,982,809 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 180,894 | USD | |
| At 2018-03-31 | 174,558 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 2,887,504 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 8,175,186 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 3,004,242 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 7,225,755 | USD | 275 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 3,579,491 | USD | |
| At 2018-03-31 | 2,383,382 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 8,819,841 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 25,809,082 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 6,788,240 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 18,691,351 | USD | 275 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 297,089 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 688,246 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 280,229 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 406,640 | USD | 275 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 29,839,168 | shares | |
| At 2018-03-31 | 29,789,168 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 4,363,788 | USD | |
| At 2018-03-31 | 4,322,838 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | -4,647,776 | USD | |
| At 2018-03-31 | 4,455,017 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 112,120,030 | USD | |
| At 2018-03-31 | 108,155,290 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 20,439,902 | USD | |
| At 2018-03-31 | 22,211,740 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 5,947,625 | USD | |
| At 2018-03-31 | 5,418,327 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 9,939,499 | USD | |
| At 2018-03-31 | 11,862,017 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 858,659 | USD | |
| At 2018-03-31 | 741,583 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 85,620 | USD | |
| At 2018-03-31 | 200,387 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 4,753,765 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 3,923,740 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 4,419,291 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 14,216,835 | USD | 275 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 4,341,341 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 12,908,820 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 2,776,412 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 8,822,659 | USD | 275 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 1,311,969 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 3,504,013 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 1,445,469 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 3,222,132 | USD | 275 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2018-12-31 | 325,040 | USD | 92 |
| 2018-04-01 to 2018-12-31 | 1,007,443 | USD | 275 |
| 2017-10-01 to 2017-12-31 | 336,599 | USD | 92 |
| 2017-04-01 to 2017-12-31 | 951,711 | USD | 275 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-12-31 | 1,007,443 | USD | 275 |
| 2017-04-01 to 2017-12-31 | 951,711 | USD | 275 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-12-31 | 951,318 | USD | 275 |
| 2017-04-01 to 2017-12-31 | 949,886 | USD | 275 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-12-31 | 100,378 | USD | 275 |
| 2017-04-01 to 2017-12-31 | 268,475 | USD | 275 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-12-31 | 3,342,017 | USD | 275 |
| 2017-04-01 to 2017-12-31 | 3,495,744 | USD | 275 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-12-31 | 1,430,058 | USD | 275 |
| 2017-04-01 to 2017-12-31 | -2,286,222 | USD | 275 |
Inspect the source
- Entity
- SPRING PHARMACEUTICAL GROUP, INC. / CIK 0000847464
- Captured
- SEC response SHA-256
21fd63bfa4a441f5dd22dbcc8093e88a40c5d63950c8b6833c77a7b4245f4dc7
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000847464.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))